BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29314171)

  • 21. Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma.
    Yoshida S; Shiraishi K; Mito T; Sayama K
    Clin Exp Dermatol; 2020 Oct; 45(7):908-911. PubMed ID: 32394515
    [No Abstract]   [Full Text] [Related]  

  • 22. A Rare Cause of Uveitis: Vemurafenib.
    Sızmaz S; Görkemli N; Esen E; Demircan N
    Turk J Ophthalmol; 2018 Dec; 48(6):323-325. PubMed ID: 30605942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bilateral Nivolumab-associated Vogt-Koyanagi-Harada-like Uveitis in a Patient with Metastatic Renal Cell Carcinoma].
    Czichos C; Wawrzynów B; Chamalis C; von Jagow B
    Klin Monbl Augenheilkd; 2021 Jun; 238(6):711-714. PubMed ID: 33395707
    [No Abstract]   [Full Text] [Related]  

  • 24. Intraocular Inflammation Associated with New Therapies for Cutaneous Melanoma - Case Series and Review.
    Fierz FC; Meier F; Chaloupka K; Böni C
    Klin Monbl Augenheilkd; 2016 Apr; 233(4):540-4. PubMed ID: 27116532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
    Park UC; Cho IH; Lee EK; Yu HG
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vogt-Koyanagi-Harada syndrome (clinical cases)].
    Sorokin EL; Voronina NV; Avramenko SY; Pomytkina NV
    Vestn Oftalmol; 2015; 131(3):90-98. PubMed ID: 26310014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choroidal thickness in eyes with posterior recurrence of Vogt-Koyanagi-Harada disease after high-dose steroid therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Acta Ophthalmol; 2014 Sep; 92(6):e490-1. PubMed ID: 24588838
    [No Abstract]   [Full Text] [Related]  

  • 29. ACUTE EXUDATIVE PARANEOPLASTIC POLYMORPHOUS VITELLIFORM MACULOPATHY DURING VEMURAFENIB AND PEMBROLIZUMAB TREATMENT FOR METASTATIC MELANOMA.
    Sandhu HS; Kolomeyer AM; Lau MK; Shields CL; Schuchter LM; Nichols CW; Aleman TS
    Retin Cases Brief Rep; 2019 Spring; 13(2):103-107. PubMed ID: 28614138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incomplete Vogt-Koyanagi-Harada disease following treatment with encorafenib and binimetinib for metastatic melanoma.
    Diamantopoulos PT; Stoungioti S; Anastasopoulou A; Papaxoinis G; Gogas H
    Melanoma Res; 2018 Dec; 28(6):648-651. PubMed ID: 30169430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 32. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
    Bricout M; Petre A; Amini-Adle M; Bezza W; Seve P; Kodjikian L; Dalle S; Thomas L
    J Immunother; 2017; 40(2):77-82. PubMed ID: 28166182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada disease: diagnosis and treatments update.
    Bordaberry MF
    Curr Opin Ophthalmol; 2010 Nov; 21(6):430-5. PubMed ID: 20829689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late posterior segment relapses in a series of Vogt-Koyanagi-Harada disease.
    Errera MH; Levinson RD; Fardeau C; Thomas D; Cohen D; Navarro A; Héron E; Paques M; Pavesio C; Sahel JA; Westcott MC; Gaudric A; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2015 Sep; 93(6):e509-10. PubMed ID: 25604241
    [No Abstract]   [Full Text] [Related]  

  • 36. Vogt-Koyanagi-Harada disease in 3-year-old boy.
    Takada S; Tanaka R; Kurita N; Ishii K; Kaburaki T
    Clin Exp Ophthalmol; 2015 Aug; 43(6):593-4. PubMed ID: 25711345
    [No Abstract]   [Full Text] [Related]  

  • 37. Case of severe acneiform eruptions associated with the BRAF inhibitor vemurafenib.
    Ansai O; Fujikawa H; Shimomura Y; Abe R
    J Dermatol; 2017 Mar; 44(3):e15-e16. PubMed ID: 27511106
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
    Tien MC; Teoh SC
    Can J Ophthalmol; 2009 Apr; 44(2):211-2. PubMed ID: 19491962
    [No Abstract]   [Full Text] [Related]  

  • 39. Severe pan-uveitis in a patient treated with vemurafenib for metastatic melanoma.
    Wolf SE; Meenken C; Moll AC; Haanen JB; van der Heijden MS
    BMC Cancer; 2013 Dec; 13():561. PubMed ID: 24289205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Ras mutation in vemurafenib-associated expanding melanocytic nevus.
    Harada K; Kato Y; Maeda T; Yoshida M; Irisawa R; Nagao T; Tsuboi R
    J Dermatol; 2017 May; 44(5):e101-e102. PubMed ID: 27790745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.